Catalent | الأصول



Assets تغيير تاريخ
Agilent USD 12.16B 244M 2025-04
AstraZeneca USD 106.25B 2.22B 2025-03
Bristol-Myers Squibb USD 92.43B 176M 2025-03
Bruker USD 5.93B 122.7M 2025-03
Centene USD 87.04B 4.6B 2025-03
Charles River Laboratories USD 7.58B 54.02M 2025-03
Cigna USD 150.66B 5.22B 2025-03
Danaher USD 79.12B 1.57B 2025-03
Dentsply International USD 6.05B 297M 2025-03
Elevance Health USD 119.72B 3.04B 2025-03
Eli Lilly USD 89.39B 10.67B 2025-03
Glaxosmithkline GBP 59.46B 1.41B 2024-12
Hologic USD 8.55B 183.6M 2025-03
Humana USD 50.93B 4.45B 2025-03
Illumina USD 6.18B 121M 2025-03
Intuitive Surgical USD 19.22B 477.2M 2025-03
IQVIA Holdings USD 27.32B 423M 2025-03
J&J USD 193.67B 13.57B 2025-03
Laboratory Of America USD 17.6B 775.2M 2025-03
Lonza CHF 19.73B 1.85B 2024-12
McKesson USD 75.14B 4.06B 2025-03
Merck EUR 49.37B 2.19B 2025-03
Merck USD 115.12B 1.98B 2025-03
Mettler Toledo International USD 3.23B 5.32M 2025-03
Novartis USD 102.25B 1.28B 2024-12
Pfizer USD 208.03B 5.37B 2025-03
Quest Diagnostics USD 15.8B 356M 2025-03
Repligen USD 2.85B 22.48M 2025-03
Revvity USD 12.36B 31.75M 2025-03
Roche Holding CHF 101.8B 6.02B 2024-12
Supernus Pharmaceuticals USD 1.37B 25.37M 2024-12
Thermo Fisher Scientific USD 99.04B 1.72B 2025-03
UnitedHealth USD 309.79B 11.51B 2025-03
Waters USD 4.59B 37.78M 2025-03
West Pharmaceutical Services USD 3.62B 25.2M 2025-03



Catalent الأصول - القيم الحالية، والبيانات التاريخية، والتنبؤات والإحصاءات والرسوم البيانية والتقويم الاقتصادي - Jul 2025.